News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
565,504 Results
Type
Article (46561)
Company Profile (125)
Press Release (518818)
Section
Business (154823)
Career Advice (2797)
Deals (29611)
Drug Delivery (115)
Drug Development (67535)
Employer Resources (163)
FDA (14739)
Job Trends (13773)
News (275939)
Policy (30211)
Tag
Academia (2589)
Alliances (40192)
Alzheimer's disease (1286)
Approvals (14713)
Artificial intelligence (210)
Bankruptcy (291)
Best Places to Work (10540)
Breast cancer (216)
Cancer (1688)
Cardiovascular disease (142)
Career advice (2328)
CAR-T (129)
Cell therapy (350)
Clinical research (54803)
Collaboration (626)
Compensation (172)
COVID-19 (2578)
C-suite (152)
Data (1565)
Diabetes (217)
Diagnostics (6138)
Earnings (56636)
Employer resources (141)
Events (74980)
Executive appointments (525)
FDA (15602)
Funding (560)
Gene therapy (261)
GLP-1 (714)
Government (4285)
Healthcare (16571)
Infectious disease (2699)
Interviews (534)
IPO (13995)
Job creations (3612)
Job search strategy (1959)
Layoffs (495)
Legal (8100)
Lung cancer (255)
Lymphoma (122)
Manufacturing (251)
Medical device (11621)
Medtech (11625)
Mergers & acquisitions (15991)
Metabolic disorders (589)
Neuroscience (1730)
NextGen: Class of 2025 (5978)
Non-profit (4373)
Northern California (1772)
Obesity (332)
Opinion (248)
Patents (173)
People (46200)
Phase I (16219)
Phase II (23869)
Phase III (19366)
Pipeline (767)
Postmarket research (2219)
Preclinical (6276)
Radiopharmaceuticals (205)
Rare diseases (321)
Real estate (5627)
Regulatory (19561)
Research institute (2310)
Resumes & cover letters (444)
Southern California (1499)
Startups (3308)
United States (15888)
Vaccines (633)
Weight loss (252)
Date
Today (80)
Last 7 days (635)
Last 30 days (2285)
Last 365 days (30025)
2025 (4642)
2024 (30758)
2023 (34567)
2022 (45003)
2021 (48766)
2020 (47668)
2019 (41840)
2018 (31776)
2017 (28697)
2016 (27532)
2015 (31623)
2014 (25027)
2013 (21908)
2012 (21016)
2011 (21667)
2010 (18835)
Location
Africa (836)
Arizona (126)
Asia (34508)
Australia (5836)
California (4055)
Canada (1565)
China (370)
Colorado (204)
Connecticut (201)
Europe (78647)
Florida (643)
Georgia (150)
Illinois (427)
Indiana (228)
Japan (123)
Maryland (602)
Massachusetts (2793)
Michigan (186)
Minnesota (255)
New Jersey (1267)
New York (1242)
North Carolina (769)
Northern California (1772)
Ohio (160)
Pennsylvania (948)
South America (1196)
Southern California (1499)
Texas (617)
Utah (153)
Washington State (413)
565,504 Results for "la roche posay".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
First Head-to-Head Study Cements Roche’s Xolair as Food Allergy Leader
Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children with one or more food allergies.
March 3, 2025
·
2 min read
·
Tristan Manalac
Pharm Country
La Roche-Posay and American Cancer Society Announce Partnership to Improve Patient and Caregiver Quality of Life
Since 1905, La Roche-Posay has been committed to improving the quality of life for those with skin conditions at the La Roche-Posay Thermal Center in France as well as through oncology initiatives globally.
August 11, 2022
·
4 min read
Earnings
Roche to Stay ‘Disciplined’ With Deals in 2025
For 2025, Roche will continue a careful approach to high-priced deals, putting science at the center of its business development decisions, executives said Thursday.
January 30, 2025
·
2 min read
·
Tristan Manalac
Neuropsychiatric disorders
Newleos Raises $93.5M to Advance Neuropsychiatric Cast-Offs from Roche
Helmed by Roche alums, Newleos Therapeutics is taking over four drugs dropped from the Swiss pharma’s pipeline in early 2024.
February 13, 2025
·
3 min read
·
Dan Samorodnitsky
Press Releases
CHMP recommends EU approval of Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma
March 3, 2025
·
10 min read
Mergers & acquisitions
Roche Nears Completion of Poseida Acquisition Worth Up to $1.5B
In a deal expected to close in Q1 2025, Roche will gain access to Poseida’s off-the-shelf CAR T candidates.
January 8, 2025
·
3 min read
·
Tristan Manalac
Immunology & inflammation
Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M
The collaboration will see COUR and Roche’s Genentech leverage the biotech’s antigen-specific immune tolerance platform to develop and commercialize therapies for an undisclosed autoimmune disease.
December 3, 2024
·
1 min read
·
Heather McKenzie
Immunology and inflammation
Roche Looks to Push Gazyva Into Lupus Nephritis With Promising Late-Stage Data
In the Phase III REGENCY study, Gazyva elicited superior complete renal response rates in patients with lupus nephritis versus placebo, positioning Roche’s therapeutic antibody for expansion into the indication.
September 27, 2024
·
2 min read
·
Tristan Manalac
Antibody drug conjugate
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
Roche has once again returned to China to bolster its antibody-drug conjugate pipeline, this time striking a licensing deal with Innovent for $1 billion in biobucks.
January 2, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Yemaachi Biotechnology Launches The African Cancer Atlas, in Partnership with Roche
February 18, 2025
·
4 min read
1 of 56,551
Next
